Diskussionsleiter: C. Stellbrink (Bielefeld), F. Straube (München)
| (P598) | Refined Atrial Fibrillation Screening and Cost-effectiveness in the German Population | |
| D. Engler, C. Wallenhorst, S. Blankenberg, N. Pfeiffer, N. A. Sprünker, M. Büttner, M. Michal, K. J. Lackner, T. Münzel, P. S. Wild, C. Martinez, B. Freedman, R. Schnabel (Hamburg, Frankfurt, Mainz; Sydney, AU) | ||
| (P599) | The role of implantable loop recorders and home monitoring after detection of atrial fibrillation in patients with cryptogenic stroke: Results from a prospective single-center database | |
| Z. Arica, M. S. Arolt, S. Dittrich, S. C. R. Erlhöfer, K. Filipovic, C. Scheurlen, J. Terporten, J.-H. van den Bruck, J. Wörmann, A. Sultan, J. Lüker, D. Steven (Köln) | ||
| (P600) | Patient characteristics influence performance of automated single-lead ECG atrial fibrillation detection | |
| M. Zink, B. Freedman, K. Mischke, A. P. Keszei, C. Rummey, N. Marx (Aachen, Schweinfurt; Sydney, AU; Basel, CH) | ||
| (P601) |
DGK-Abstract-Preis 2021: |
|
| C. S. Börschel, B. Geelhoed, S. Camen, T. Niiranen, A. S. Havulinna, T. Palosaari, P. Jousilahti, J. Kontto, K. Kuulasmaa, V. Salomaa, E. Vartiainen, S. Blankenberg, F. Ojeda-Echevarria, T. Zeller, L. Iacoviello, S. Costanzo, M. B. Donati, D. G. Giovanni, F. Gianfagna, A. Di Castelnuovo, S. Söderberg, A. Linneberg, J. K. Vishram-Nielsen, M.-L. Løchen, G. Pasterkamp, H. M. den Ruijter, W. König, T. Jørgensen, R. Schnabel, für die Studiengruppe: BiomarCaRE (Hamburg, Magdeburg; Helsinki, FI; Pozzilli, Varese, Napoli, IT; Umeå, SE; Frederiksberg, DK; Tromsø, NO; Utrecht, NL) | ||
| (P602) | Apixaban For Treatment of Embolic Stroke Of Undetermined Source - ATTICUS Randomized Trial- Update of patient characteristics and study timeline after interim analysis | |
| T. Geisler, T. Keller, C. Meisner, H. Bäzner, E. Schmid, A. Kraft, F. Hoffmann, C. Hobohm, F. Hillenbrand, L. Niehaus, J. Liman, R. Wachter, M. Gawaz, M. Schabet, H. Kimmig, W. Jung, C. Hendrich, R. Dziewas, R. Huber, D. Lewis, A. Lindner, G. Petzold, M. Görtler, F. Bode, J. Meyne, K. Althaus, U. Ziemann, S. Poli, für die Studiengruppe: ATTICUS (Tübingen, Stuttgart, Halle, Merseburg, Winnenden, Göttingen, Leipzig, Ludwigsburg, Villingen-Schwenningen, Friedrichshafen, Münster, D-53127 Bonn, Magdeburg, Kiel, Ulm) | ||
| (P603) | The dilute Russel´s viper venom time – a helpful tool to detect direct oral anticoagulants Observations in a real life setting | |
| T. Klöter, M. Metze, T. Siegemund, A. Siegemund, U. Laufs, S. Petros (Leipzig) | ||
| (P604) | Safety and short-term efficacy of PVI in obese patients Retrospective analysis from a large tertiary center | |
| J. Wolfes, C. Ellermann, D. Hoppe, K. Willy, P. Leitz, P. S. Lange, F. Reinke, P. Müller, J. Köbe, K. Wasmer, L. Eckardt, G. Frommeyer (Münster) | ||
| (P605) | Effect of diabetes mellitus on freedom from arrhythmia recurrence following cryoballoon ablation in patients with atrial fibrillation | |
| D. Guckel, K. Isgandarova, L. Bergau, M. El Hamriti, G. Imnadze, M. Braun, M. Khalaph, Y. H. Lee-Barkey, D. Tschöpe, P. Sommer, C. Sohns (Bad Oeynhausen) | ||
| (P606) | Is temporally sinus rhythm in patients with atrial fibrillation a reason NOT to perform a concomitant surgical ablation during cardiac surgery? | |
| M. Vondran, T. Ghazy, M. Albert, H. Warnecke, M. Doss, A. Liebold, E. Eszlari, T. Ouarrak, N. Doll, J. Senges, T. Hanke, A. Rastan, für die Studiengruppe: CASE-AF (Rotenburg, Stuttgart, Bad Rothenfelde, Bad Nauheim, Ulm, München, Ludwigshafen am Rhein, Hamburg) | ||
| (P607) | Vergleich von vier 1-Kanal-EKG-wearables während einer 2-wöchigen Alltagserprobung bei 80 Pat. mit Herzrhythmusstörungen | |
| T. Wendt, V. Peterschik, K. Koberg (Frankfurt am Main) |